KRTAP19-9P

Across TCGA pan-cancer cohorts, KRTAP19-9P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated KRTAP19-9P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher KRTAP19-9P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP19-9P expression acts as an unfavorable survival marker, although some lineages such as UCS show a favorable association.

HNSC, LIHC, and KIRC are the cancer types where KRTAP19-9P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	II,III,IV	0.082	0.711	<.001	84	view →
LIHC	DFS	Tertile	All	0.169	0.548	<.001	63	view →
KIRC	DFS	Tertile	IV	0.165	0.624	.004	36	view →
BLCA	DFS	Tertile	All	0.159	0.625	.016	27	view →
UCS	DFS	Tertile	III,IV	1.000	0.222	.046	12	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

KRTAP19-9P–HNSC (OS)

Open the HNSC breakdown →